Cigna’s first-quarter report shows strong numbers, but Barclays warns the road ahead could get rocky. Barclays highlights ...

Guardant Health's Shield test receives FDA breakthrough status and NCCN guideline inclusion, with high accuracy shown in new ...

Bristol Myers Squibb recently closed at $48.79, rising 1.06%, easily outpacing the S&P 500’s 0.41% gain. Despite this, the ...